Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation.
about
The fungal pattern recognition receptor, Dectin-1, and the associated cluster of C-type lectin-like receptorsTargeting C-Type Lectin Receptors for Cancer ImmunityExpression and functional role of MDL-1 (CLEC5A) in mouse myeloid lineage cellsThe two main forms of histiocytic sarcoma in the predisposed Flatcoated retriever dog display variation in gene expressionRat macrophage C-type lectin is an activating receptor expressed by phagocytic cells.Inhibitory C-type lectin receptors in myeloid cells.Recognition of Aspergillus fumigatus hyphae by human plasmacytoid dendritic cells is mediated by dectin-2 and results in formation of extracellular traps.Integrated Genomics of Crohn's Disease Risk Variant Identifies a Role for CLEC12A in Antibacterial AutophagyCharacterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand.Syk kinase is required for collaborative cytokine production induced through Dectin-1 and Toll-like receptors.The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex.Modulation of monosodium urate crystal-induced responses in neutrophils by the myeloid inhibitory C-type lectin-like receptor: potential therapeutic implications.CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.CLEC-2 signaling via Syk in myeloid cells can regulate inflammatory responses.A multi-laboratory comparison of blood dendritic cell populations.Differentiation of human monocytes and derived subsets of macrophages and dendritic cells by the HLDA10 monoclonal antibody panel.The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.MICL controls inflammation in rheumatoid arthritis.Nomenclature of CD molecules from the Tenth Human Leucocyte Differentiation Antigen Workshop.Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset.IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils.Expression of the hMICL in acute myeloid leukemia-a highly reliable disease marker at diagnosis and during follow-up.CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia.C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets.Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34+ Acute Myeloid Leukemia.Cell-surface C-type lectin-like receptor CLEC-1 dampens dendritic cell activation and downstream Th17 responsesThe Role of Inhibitory Receptors in Monosodium Urate Crystal-Induced Inflammation
P2860
Q24654154-1E74ACFB-1971-4B06-A6F3-7DFB4F96763EQ26784483-6B880911-174C-4F41-BB3B-8835C6597DA5Q28511564-5A8DB24C-8510-442D-A0EB-4A14DCE33CFEQ33700016-25B7FB9C-D30C-4354-A1AA-671366987223Q34612088-F1B771A9-B46C-4FF1-BAF0-4A2F18223D8FQ34700805-8079CA93-3CC6-42CC-8A67-B0186E30B25FQ35557248-746BE435-D42A-492D-8A76-D1017A05CD86Q35866292-B5CFCF99-D642-4D62-8DE0-097198CCDF8AQ36725571-A3389A14-A4C9-40B0-8484-B60371462FF6Q36725577-6743573D-FFDE-4348-A599-CB3D046AF381Q38025997-DA8F86C3-A0BD-4293-A82D-A5C8EBCBCCA8Q38649946-459F32C7-BBAB-4FDC-86C2-0E8F66448D87Q39448429-0ABAE220-2C46-4102-9243-455A5D1C6B08Q39512759-70029C20-04F2-45CA-9EB5-DB5B285DF576Q39754362-86C9628A-416B-4267-A8F2-1DB5AE4691E2Q39979829-E985CBA7-714F-4AC3-B99D-41B7BAE2C94CQ40130660-968469D7-0B44-48F7-837A-450606C7DC34Q40483682-86FDF4EC-E7A7-433A-BB76-3375F4FCE5B6Q41051379-C34740A6-52E5-4294-A54B-5B927E8BB1A6Q41882122-34B8CE26-AAD9-48A4-874F-DABF9889B812Q42143775-6F924DE2-0238-4084-B53D-931E6E909F2EQ42370805-22B0FB70-C8CB-4617-A9DC-62F84CCAF4F5Q44059514-D11A4B94-0BB8-4F1A-AED2-0F7713821159Q49168672-04688979-78CB-4180-B1F3-5FE844D19548Q50351148-4CA2823B-AD54-4A06-84FF-25588F9F32B0Q53110546-43489D88-A9E8-468B-9209-0A32352D784CQ56975145-85CB7BF0-B26F-487E-8835-DEBCECC7DFCAQ57168449-2DCA373D-C2A3-49CE-96FD-E499C236EADD
P2860
Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human MICL (CLEC12A) is differ ...... following cellular activation.
@ast
Human MICL (CLEC12A) is differ ...... following cellular activation.
@en
Human MICL
@nl
type
label
Human MICL (CLEC12A) is differ ...... following cellular activation.
@ast
Human MICL (CLEC12A) is differ ...... following cellular activation.
@en
Human MICL
@nl
prefLabel
Human MICL (CLEC12A) is differ ...... following cellular activation.
@ast
Human MICL (CLEC12A) is differ ...... following cellular activation.
@en
Human MICL
@nl
P2093
P2860
P356
P1476
Human MICL (CLEC12A) is differ ...... following cellular activation.
@en
P2093
Andrew S J Marshall
Delyth M Reid
Elwira Pyz
Gordon D Brown
Janet A Willment
Kevin M Dennehy
Pietro Dri
Simon Y C Wong
P2860
P304
P356
10.1002/EJI.200535628
P407
P577
2006-08-01T00:00:00Z